{
    "Trade/Device Name(s)": [
        "Elecsys Folate III"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K233060",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103716"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGN"
    ],
    "Summary Letter Date": "June 17, 2024",
    "Summary Letter Received Date": "May 2, 2024",
    "Submission Date": "May 2, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.1295"
    ],
    "Regulation Name(s)": [
        "Folic Acid Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Folate"
    ],
    "Specimen Type(s)": [
        "Erythrocytes",
        "Whole Blood",
        "Hemolysate"
    ],
    "Specimen Container(s)": [
        "Na-Heparin tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e immunoassay analyzers",
        "cobas e 801 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Competitive binding assay"
    ],
    "Methodologies": [
        "Quantitative binding assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Folate III competitive electrochemiluminescence immunoassay for folate measurement in erythrocytes using cobas e analyzers",
    "Indications for Use Summary": "Binding assay for the in vitro quantitative determination of folate in erythrocytes (RBCs); folate measurements are used in the diagnosis and treatment of anemia and intended for use on cobas e immunoassay analyzers.",
    "fda_folder": "Clinical Chemistry"
}